期刊文献+

儿童体位性心动过速综合征血清中一氧化氮浓度变化的探讨 被引量:1

Concentration of Serum Nitric Oxide in Postural Orthostatic Tachycardia Syndrome
下载PDF
导出
摘要 目的探讨儿童体位性心动过速综合征(POTS)血清中一氧化氮浓度的变化。方法选择POTS患者60例,其中男22例,女38例,男∶女约为1∶1.7。选取年龄、性别相匹配的健康对照组60例,观察其各种临床表现的发生频率及辅助检查结果。取其静脉血测定血清NO和NOS浓度。结果诊断为POTS的患儿60例,在直立试验或直立倾斜(HUT)试验过程中,POTS患儿最常见的异常表现为在直立或倾斜后10min内,心率增加≥35次/min,或患儿心率测最大值≥120次/min。出现异常表现的时间平均为7±2min,21例直立6min出现异常症状,16例在直立后即可出现异常症状,23例作HUT约10min内出现异常症状。POTS组与对照组比较,NO浓度和eNOS活性均显著下降。结论POTS组与对照组比较,NO浓度和NOS活性显著下降,提示NO和eNOS在POTS发病机制中有重要作用。 Objective The aim of this article is to analyze the concentration of serum nitric oxide of POTS in children.Methods All 60 pediatric patients of POTS, 22 males and 38 females with a ratio of male to female 1:1.7 met the diagnostic criteria and were investigated. Another 60 age- and sex-matched healthy children were as controls. The serum of subjects were collected and centrifuged to measure the NO and NOS level. Results 60 patients were diagnosed as POTS. During the head-up or head-up tilt test, POTS cases had the heart rates increased ≥ 30 per min,or the max heart rates≥ 120 per min within 10 min.The average time of the occurrence of abnormal responses was about (7±2)min. There was abnormal symptom in 21 patients within 6 minutes, 16 patients in 10 immediately after standing up, and 23 patients within 10 minutes after HUT, respectively. The serum levels of NO and eNOS activity in POTS group were significantly decreased than those in control group. Conclusion The levels of NO and eNOS in POTS group were significantly decreased than those in control group, which suggests that NO and eNOS play important roles in POTS.
出处 《医学信息》 2009年第8期1529-1531,共3页 Journal of Medical Information
关键词 体位性心动过速综合征 一氧化氮 Postural orthostatic tachycardia syndrome Concentration of nitric oxide
  • 相关文献

参考文献7

  • 1Grubb BE Kanjwal Y,Kosinski DJ.The postural tachyeardia syndrome:a concise guide to diagnosis and management[J].J Cardiovase Eieetrophysiol 2006;17:108-112.
  • 2张清友,杜军保,李万镇.儿童体位性心动过速综合征的临床特征及随访研究[J].中华儿科杂志,2005,43(3):165-169. 被引量:87
  • 3Garland EM,Winker R,Williams SM,et al.Endothelial NO synthase polymorphisms and postural tachycardia syndrome[J].Hypertension 2005;46:1103-1110.
  • 4杜军保,陈丽.儿童体位性心动过速综合征[J].中国实用儿科杂志,2008,23(7):481-482. 被引量:9
  • 5Stewart JM,Taneja I,Glover J,et al.AnglotensinⅡtype 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome.Am J Physiol Heart Circ Physioi 2008;294:H466-473.
  • 6Masuki S,Eisenach JH,Schrage WG,et al.Reduced stroke volume during exercise in postural tachycardia syndrome.J Appl Physiol 2007;103:1128-1135.
  • 7Stewart JM,Medow MS,Minson CT,et al.Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome[J].Am J Physiol Heart Circ Physiol 2007;293:2161-2167.

二级参考文献27

  • 1李雯,王成,李茗香,林萍,郑慧芬,谢振武.儿童血管迷走性晕厥的诱因与先兆分析[J].中国急救医学,2006,26(2):87-89. 被引量:14
  • 2简佩君,杜军保,张清友.美托洛尔治疗儿童血管迷走性晕厥的效果[J].实用儿科临床杂志,2006,21(5):305-306. 被引量:16
  • 3Low PA, Opfer-Gehrking TI, Textor SC, et al. Postual tachycardia syndrome(POTS) [ J]. Neurology, 1995,45 : 19-25.
  • 4Stewart JM. Orthostatie intolerance in pediatrics [ J]. J Psdiatr, 2002,140:404-411.
  • 5Brady PA, Low PA, Shen WK. Inappropriate sinus tachy cardia, postural orthostatic tachycardia syndrome, and overlapping syndromes[ J ]. PACE ,2005,28 : 1112-1121.
  • 6Yousaf kanjwal, Dankosinski, Grubb BP. The postural orthostatic tachycardia syndrome: Definitions, Diagnosis, and Management [J]. Pacing and Clinical Electrophysiology, 2003, 26: 1747- 1757.
  • 7C. J, Mathias ,T, M. Young, Water drinking in the management of orthostatic intolerance due to orthostatic hypotension, vasovagal syncope and the postural tachycardia syndrome [ J ]. European Journal of Neurology ,2004,11:613-619.
  • 8Grubb BP, Karas B, Kosinski D, et al. Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope[ J ]. J Interv Card Electrophysiol, 1999,3 : 139-143.
  • 9Salim MA, Di Sessa TG. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial [ J ]. J Am Coll Cardiol, 2005,45 ( 4 ) :484-488.
  • 10Scott WA,Pongiglione G, Bromberg BI, et al. Randomized comparison of atenotol and fludrocortison acetate in the treatment of pediatric neurally mediated syncope [ J ]. Am J Cardiol, 1995, 76:400-402.

共引文献91

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部